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Open access under the ElsThe emergence of drug-resistant strains of Mycobacterium tuberculosis, the major causative agent of
tuberculosis (TB), and the deadly HIV-TB co-infection have led to an urgent need for the development
of new anti-TB drugs. The histidine biosynthetic pathway is present in bacteria, archaebacteria, lower
eukaryotes and plants, but is absent in mammals. Disruption of the hisD gene has been shown to be
essential forM. tuberculosis survival. Here we present cloning, expression and puriﬁcation of recombinant
hisD-encoded histidinol dehydrogenase (MtHisD). N-terminal amino acid sequencing and electrospray
ionization mass spectrometry analyses conﬁrmed the identity of homogeneousMtHisD. Analytical gel ﬁl-
tration, metal requirement analysis, steady-state kinetics and isothermal titration calorimetry data
showed that homodimeric MtHisD is a metalloprotein that follows a Bi Uni Uni Bi Ping-Pong mechanism.
pH-rate proﬁles and a three-dimensional model of MtHisD allowed proposal of amino acid residues
involved in either catalysis or substrate(s) binding.
 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
The World Health Organization (WHO) declared tuberculosis
(TB)1 as a global emergency in 1993. Unfortunately, the efforts
made by the Stop TB Strategy were not enough to impede the
occurrence of 1.3 million deaths in 2009 [1]. However, WHO esti-
mates that the number of cases per capita peaked at 2004 and is
slowly falling [2]. Nonetheless, the battle against TB is far from
over, since Mycobacterium tuberculosis (the main causative agent
of TB) proved to be highly adaptive [3] and capable of evading
the current strategies for treatment of 0.5 million cases of multi-ecnopuc, Prédio 92A, Porto
antos), luiz.basso@pucrs.br
S, directly observed treatment
pectrometry; HisD, histidinol
side; ITC, isothermal titration
al, L-histidinaldehyde; L-His,
bacterium tuberculosis HisD;
denine dinucleotide, oxidized
ced form; PDB, Protein Data
deviation; TB, tuberculosis;
ug-resistant.
evier OA license.drug-resistant TB (MDR-TB) that were reported in 2007, including
cases of extensively drug-resistant TB (XDR-TB) [2], and the more
recently reported totally drug-resistant strains (TDR-TB) [4,5]. To
compound the problem further, the deadly association with human
immunodeﬁciency virus makes the treatment of co-infected
patients even more challenging [2]. Accordingly, novel TB
treatments should, hopefully, reduce the duration of short-course
treatment, lower the dose frequency, reduce the pill burden, and
present low drug–drug interactions [6].
The histidine biosynthetic pathway has been studied in detail in
Salmonella typhimurium and Escherichia coli. There are 10 enzy-
matic reactions carried out by eight gene products in the
unbranched pathway that include several complex and unusual
reactions, and form a critical link between amino acid and purine
biosynthesis [7]. The ﬁnal reaction, ﬁrst described in Arthrobacter
histidinovorans and E. coli [8], and in yeast [9], is catalyzed by
histidinol dehydrogenase (HisD) [L-histidinol:NAD oxidoreductase
(EC 1.1.1.23)]. HisD is a bifunctional enzyme that catalyzes the
NAD+- and Zn2+-dependent conversion of L-histidinol (L-Hol) to
L-histidine (L-His) through an L-histidinaldehyde (L-Hal) intermedi-
ate [8–10], with the concomitant reduction of 2 mol of NAD+
(Fig. 1A). Previously described HisD enzymes are homodimers
[11,12] containing one Zn2+ per subunit [11]; and they are
Fig. 1. Chemical reaction catalyzed by HisD. (A) HisD catalyzes the NAD+- and Zn2+-dependent conversion of L-Hol to L-His through an L-Hal intermediate, with the
concomitant reduction of 2 mol of NAD+. (B) Proposed Bi Uni Uni Bi Ping-Pong enzyme mechanism for MtHisD-catalyzed chemical reaction.
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pointed out that relatively few other NAD+-linked oxidoreductases
seem to require a bound metal for activity [13].
The histidine biosynthetic pathway is present in bacteria,
archaebacteria, lower eukaryotes and plants, but is absent in
mammals [14]. Analysis of the complete genome sequence of
M. tuberculosis H37Rv strain predicted the presence of the coding
sequences for the histidine biosynthetic pathway enzymes [15].
The inability of histidine auxotrophs to survive single-amino-acid
starvation [16], the identiﬁcation of genes required for mycobacte-
rial growth [17], and the essentiality of the hisD gene product for
M. tuberculosis survival [18] suggest that HisD is a promising target
for antitubercular agent development. Not surprisingly, HisD has
been ranked among the top 50 targets by the TDR Targets database
[19]. However, it has not been shown yet whether the hisD gene
codes for a histidinol dehydrogenase activity as predicted by in
silico analysis of M. tuberculosis genome sequence.
The target-based rational design of new agents with anti-TB
activity includes functional and structural efforts. However, the
ﬁrst step to enzyme target validation must include experimental
data demonstrating that a gene predicted by in silico analysis to
encode a particular protein catalyzes the proposed chemical reac-
tion. Moreover, recognition of the limitations of high-throughput
screening approaches in the discovery of candidate drugs has
rekindled interest in rational design methods. Understanding the
mode of action of MtHisD should thus inform us on how to better
design inhibitors targeting this enzyme with potential therapeutic
application in TB chemotherapy.
Here we present cloning, expression, puriﬁcation to homogene-
ity, steady-state kinetics, pH-rate proﬁles, metal requirement
studies, isothermal titration calorimetry data on ligand binding,
and molecular homology model building of MtHisD. These data
prompted the proposal that MtHisD follows a Bi Uni Uni Bi Ping-
Pong mechanism. In addition, these studies indicated the likely
amino acid residues involved in acid–base catalysis and/or sub-
strate binding. These studies should provide a framework on which
to base the rational design of MtHisD enzyme inhibitors to be
tested as antiTB agents.
Materials and methods
PCR ampliﬁcation, cloning and overexpression of recombinant M.
tuberculosis hisD-encoded protein
Synthetic oligonucleotide primers (50-ccatatgcttacccgtatcgac-
ttgcggggag-30 and 50-tcaagcttgtcatcgctcgaacctccgccgtac-30) were
designed to be complementary to, respectively, the amino-termi-
nal coding and carboxy-terminal noncoding strands of hisD
(Rv1599 locus) gene containing 50 NdeI and 30 HindIII restriction
sites (in bold), and the start and stop codons (in italics). Theseprimers were used to amplify the M tuberculosis hisD structural
gene (1317 bp) from genomic DNA using standard PCR conditions
(Perkin–Elmer) with a hot start at 99 C for 10 min. The ampliﬁed
fragment was puriﬁed with CONCERT Nucleic Acid Puriﬁcation
System (Gibco BRL), digested with NdeI (Invitrogen) and HindIII
(Gibco BRL), and ligated into a pET-23a(+) expression vector (Nova-
gen). The DNA sequence of the M. tuberculosis hisD structural gene
was determined using an ABI-PRISM 3100 Genetic Analyzer (Ap-
plied Biosystems) to both conﬁrm the identity of the cloned DNA
and ensure that no mutations were introduced by the PCR ampliﬁ-
cation step.
Overexpression was achieved by transforming electrocompe-
tent E. coli BL21(DE3) host cells with pET-23a(+)::hisD recombinant
plasmid and grown on Luria–Bertani (LB) medium containing
50 lg mL1 carbenicillin at 37 C for 18 h after reaching
OD600nm = 0.4 without induction by isopropyl b-D-thiogalactopyra-
noside (IPTG). Cells were harvested by centrifugation at 12,000g for
15 min at 4 C, and stored at 20 C.
Protein puriﬁcation
Approximately 9 g of wet cell paste were suspended in 45 mL of
100 mM Pipes pH 6.0 (buffer A), treated with lysozyme
0.2 mg mL1 at 4 C for 30 min with gentle stirring, disrupted by
sonication with 8 pulses of 15 s each at 60% amplitude with a
13 mm probe. This solution was centrifuged at 48,000g for
30 min at 4 C, and 10 mM MgCl2 (ﬁnal concentration) and 2000
units of bovine pancreas DNAse I (Sigma) were added to the solu-
ble fraction (40 U mL1) under gentle stirring at 4 C for nucleic
acid removal. This mixture was centrifuged at 48,000g at 4 C for
30 min and the supernatant dialyzed against buffer A before being
loaded on a Q Sepharose Fast Flow 26/10 (GE Healthcare) column
using an Äkta Puriﬁer (GE Healthcare). The column was washed
with 4 bed volumes of buffer A and adsorbed protein elution was
carried out using a linear gradient of 0–0.5 M NaCl in buffer A.
The recombinant M. tuberculosis histidinol dehydrogenase
(MtHisD) protein eluted at approximately 200 mMNaCl concentra-
tion. Fractions were pooled and concentrated using an ultraﬁltra-
tion membrane with 30 kDa molecular weight cut off (MWCO)
and loaded on a HiLoad Superdex 200 26/60 (GE Healthcare) pre-
equilibrated with 100 mM Pipes pH 7.2 (buffer B) at 0.8 mL min1.
Fractions containing MtHisD were pooled and loaded on a Mono Q
HR 16/10 column (GE Healthcare) equilibrated with buffer B. The
column was washed with 2 bed volumes of buffer B and adsorbed
protein eluted with a linear 0–0.3 M NaCl gradient in buffer B. Frac-
tions containing homogeneous recombinantMtHisD were dialyzed
against buffer B, and stored at 80 C.
Protein concentration was determined by the method of
Bradford [20] using the Bio-Rad protein assay kit (Bio-Rad) and
bovine serum albumin as standard.
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Automated Edman degradation was performed with homoge-
neous MtHisD using a gas-phase sequencer PPSQ-21 A (Shimadzu)
to verify N-terminal amino acid sequence. MtHisD was also ana-
lyzed by electrospray ionization mass spectrometry (ESI-MS)
according to Chassaigne and Lobinski, with some adaptations
[21]. The sample was analyzed on Quattro-II triple-quadrupole
mass spectrometer (Micromass; Altrincham, UK). During all exper-
iments, the source temperature was maintained at 80 C and the
capillary voltage at 3.6 kV; a drying nitrogen gas ﬂow (200 L h1)
and a nebulizer gas ﬂow (20 L h1) were used. The mass spectrom-
eter was calibrated with intact horse heart myoglobin and its typ-
ical cone voltage-induced fragments. About 50 pmol (10 ll) of each
sample was injected into the electrospray transport solvent. The
ESI spectrum was obtained in the multichannel acquisition mode,
with scanning from 500 to 1800 m/z at a scan time of 7 s. The mass
spectrometer is equipped with MassLynx and Transform software
for data acquisition and spectrum handling.
Determination of molecular mass and oligomeric state of MtHisD in
solution
Analytical gel ﬁltration was performed using a Superdex 200
HR 10/30 (GE Healthcare) column pre-equilibrated with 50 mM
Tris HCl pH 7.5 containing 200 mM NaCl at a ﬂow rate of
0.4 mL min1, with UV detection at 215, 254 and 280 nm. Homo-
geneous recombinant MtHisD was previously dialyzed against the
same buffer. The LMW and HMW Gel Filtration Calibration Kits
(GE Healthcare) were used to prepare a calibration curve. The elu-
tion volumes (Ve) of standard proteins (ferritin, catalase, aldolase,
coalbumin, ovalbumin, ribonuclease A) were used to calculate
their corresponding partition coefﬁcient (Kav, Eq. (1)). Blue dex-
tran 2000 (GE Healthcare) was used to determine the void vol-
ume (Vo). Vt is the total bead volume of the column. The Kav
value for each protein was plotted against their corresponding
molecular mass.Kav ¼ Ve  VoV t  Vo ð1ÞHistidinol dehydrogenase assay
HisD catalyzes the sequential NAD+-dependent oxidations of
L-Hol to L-Hal and then to L-His. The enzymatic activity was
assayed in the forward direction at 25 C by continuously monitor-
ing the increase in absorbance at 340 nm due to the conversion of
NAD+ to NADH (eNADH = 6.22  103 M1 cm1) [22]. One unit of
enzyme activity (U) is deﬁned as the amount of enzyme catalyzing
the conversion of 1 lmol of substrate per minute. Enzyme inacti-
vation, divalent metal ion activation and determination of stea-
dy-state kinetic constants were carried out in 50 mM Pipes pH
7.2. The curves were plotted and steady-state parameters were
determined using the nonlinear regression function of Sigma Plot
9.0.
Inactivation by chelating agents
Histidinol dehydrogenases from other organisms have been
described as Zn2+ metalloenzymes [12,13,23]. In order to investi-
gate whether MtHisD belongs to this class, measurements of
enzyme activity were carried out in the presence of 0.1, 1 and
10 mM EDTA and 1, 2 and 5 mM 1,10-phenantroline. All buffers
were rendered metal free by treatment with Chelex resin (Bio-
Rad).Divalent metal ion activation
To assess the ability of different divalent metal ions to activate
MtHisD enzyme activity, homogeneous enzyme was inactivated
with 5 mM 1,10-phenantroline for 5 min and then diluted 10-fold
as described by Charles Grubmeyer [13]. After dilution, 10 lL sam-
ples were assayed in the presence of Ca2+, Cd2+, Co2+, Mg2+, Mn2+,
Ni2+ and Zn2+.
Inductively coupled plasma atomic emission spectroscopy (ICP-AES)
analysis of metal content
A semi-quantitative analysis was performed to investigate the
divalent metals present in the protein sample. A quantitative anal-
ysis of Mn2+ and Zn2+ concentrations in MtHisD homogeneous pro-
tein solution was carried out by ICP-AES (Spectro Ciros CCD).
Recombinant homogeneous MtHisD was extensively dialyzed
against Pipes 100 mM pH 7.2 and concentrated by ultraﬁltration
to a ﬁnal protein concentration of 8 mg mL1 (enzyme subunit
concentration = 8 mg mL1/45378.2 Da = 176.3 lM).
Determination of steady-state kinetic parameters and enzyme
mechanism
To determine the true steady-state kinetic constants and initial
velocity patterns,MtHisD activity was measured in the presence of
variable concentrations of L-Hol (10–250 lM) and several ﬁxed-
varied concentrations of b-NAD+ (1–25 mM). Steady-state parame-
ters were calculated by ﬁtting the initial velocity data to Eq. (2)
[24]. This equation describes the velocity equation in the absence
of products for a Bi Uni Uni Bi Ping Pong Ter Ter System assuming
that [B] = [C] and KB = KC, in which v is the initial velocity, Vmax is
the maximal initial velocity, A and B are the concentrations of
the substrates (L-Hol and b-NAD+), KA and KB are their respective
Michaelis constants, and KiA is the dissociation constant for en-
zyme-substrate A (MtHisD:L-Hol) binary complex formation.
V ¼ Vmax½A½B
Ki;AKB þ 2KB½A þ KA½B þ ½A½B ð2ÞIsothermal titration calorimetry (ITC) measurements of ligand binding
Isothermal titration calorimetry (ITC) using an iTC200 micro-
calorimeter (Microcal, Inc., Northampton, MA) was performed to
assess the enzyme interaction with its substrates and products.
ITC measurements were carried out at 25 C, and titrations were
performed using a 39 lL-syringe, with stirring at 500 rpm. Each
titration consisted of a preliminary injection of 0.5 lL, followed
by 10 injections of 3.85 lL and 180 s intervals between injections,
into a cell containing 200 lL of protein sample at 69 lM for sub-
strates and 131 lM for products. Ligand concentrations were
400 lM (L-Hol), 800 lM (L-His) and 50 mM (NAD+ or NADH). To ac-
count for dilution and mixing effects, control experiments were
performed injecting ligand into buffer instead of protein in the cell.
The control data were subtracted to obtain accurate values for heat
changes. The Gibbs free energy (DG) of binding was calculated
using the relationship described in Eq. (3), in which R is the gas
constant (8.314 J K1 mol1), T is the temperature in Kelvin
(T = C + 273.15), and Ka is the association constant at equilibrium.
The entropy of binding (DS) can also be determined from this
mathematical formula. One set of sites model was utilized to deter-
mine the binding and thermodynamic constants. Estimates for Ka
and the binding enthalpy (DH) were reﬁned by standard Marqu-
ardt nonlinear regression method provided in the Origin 7 SR4
software.
DGo ¼ RT ln Ka ¼ DHo  TDSo ð3Þ
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To assess the role of acid/base chemistry in the MtHisD enzy-
matic reaction, apparent steady-state kinetic constants were deter-
mined in a composite buffer (100 mM Mes/Hepes/Ches) with pH
values ranging from 7.5 to 11.0. The catalytic constants (kcat) and
the speciﬁcity constants (kcat/KM) for each substrate were plotted
in the logarithm form against pH. The pH-rate proﬁles were ﬁtted
to either Eq. (4) or Eq. (5) [25], in which y is the kinetic parameter
(kcat or kcat/KM), C is the pH-independent value of y, 10pH is the
proton concentration, and Ka and Kb are, respectively, the apparent
acid and base dissociation constants for ionizing groups.
logy ¼ log C
1þ 10pHKa
 !
ð4Þ
logy ¼ C
1þ KbKa þ 10
pH
Ka
þ Kb
10pH
 !
ð5Þ
Data described in Fig. 5A and B were best ﬁtted to Eq. (4), which de-
scribes a pH-rate proﬁle for a group that needs to be unprotonated
(slope of +1) for catalysis (kcat) or L-Hol substrate binding (kcat/KM).
Data given in Fig. 5C were best ﬁtted to Eq. (5), which describes a
bell-shaped pH-rate proﬁle for a single ionizing group in the acidic
limb that must be unprotonated (slope of +1) for NAD+ binding and
participation of a single ionizing group in the basic limb that must
be protonated for substrate binding (slope of 1). It should be
pointed out that Eq. (5) describes a bell-shaped pH-rate proﬁle in
which the two pKs are less than a pH unit apart [25].
Molecular homology model building
The search for templates for the MtHisD target sequence was
performed with Blastp [26]. The structure of the homologous
E. coli protein was selected from the Protein Data Bank (PDB)
[27], which was solved experimentally by X-ray diffraction at
1.7 Å resolution (PDB ID: 1KAE). Target and template sequence
alignment was performed with ClustalW [28] and required small
gaps in both M. tuberculosis and E. coli HisD amino acid sequences
(insertions and/or deletions).
MtHisD protein models were built with restrained-based mod-
eling implemented in MODELLER9v1 [29], with the standard proto-
col of the comparative protein structure modeling methodology, by
satisfaction of spatial restrains [30,31]. The best models were
selected according to MODELLER objective function [32] and were
subject to energy minimization and stereochemical analysis with
PROCHECK [33]. Each subunit of MtHisD homodimer was modeled
independently based on the E. coli structure, in which subunit A is
in the apo form and subunit B has both substrates, histidinol and
NAD+, bound to its active site. Atomic coordinates of heteroatom
Zn2+ present in both subunits were copied from the template struc-
ture into the MtHisD model. Prior to energy minimization, the
homodimeric structure was assembled based on the template
structure with LEaP module of AMBER7 package [34].
Energy minimization
Energy minimization of the best models were performed with
GROMACS package [35] using the 43a1 force-ﬁeld. The system
was submitted to an initial steepest descent energy minimization
in vacuo with a maximum number of 400 minimization steps,
followed by a maximum of 3000 steps of conjugate gradient energy
minimization. Identities between the ﬁnal minimized model of
MtHisD and the template were evaluated by their root-meansquare deviation (RMSD). Figures were prepared with the PyMOL
v0.98 graphics package [36].Results and discussion
Ampliﬁcation, cloning, expression and puriﬁcation of recombinant M.
tuberculosis histidinol dehydrogenase (MtHisD)
The probable hisD structural gene was PCR ampliﬁed from M.
tuberculosis H37Rv genomic DNA. The presence of 10% DMSO in
the reaction mixture proved to be necessary to obtain a PCR prod-
uct (data not shown). The DMSO cosolvent helps overcome poly-
merase extension difﬁculties due to DNA secondary structures
and improves the denaturation of GC-rich DNAs [37], which is con-
sistent with the 65.6% G + C content ofM. tuberculosis genome [15].
The PCR product was cloned into pET-23a(+) expression vector
between NdeI and HindIII restriction sites. Nucleotide sequence
analysis of the cloned DNA fragment conﬁrmed the identity of
the insert as M. tuberculosis hisD coding sequence (1317 bp) and
demonstrated that no mutations were introduced by the PCR
ampliﬁcation step.
Histidinol dehydrogenase from M. tuberculosis H37Rv (MtHisD)
was overexpressed in E. coli BL21(DE3) electrocompetent host cells
transformed with pET-23a(+)::hisD recombinant plasmid. To eval-
uate recombinant MtHisD expression as a function of time, cell
growth was tested for 3, 6, 12, 18, 24, and 48 h at 37 C either with
or without IPTG induction. SDS–PAGE analysis revealed a higher
yield of soluble recombinant protein in the absence of IPTG for cells
grown for 18 h (data not shown). Interestingly, the recombinant
MtHisD protein overexpression was achieved with no addition of
the inducer. The pET system makes use of a highly processive T7
RNA polymerase under control of the IPTG-inducible lacUV5 pro-
moter for the transcription of target genes of interest [38]. Reports
have demonstrated that high levels of protein production can be
obtained in the stationary phase of cell growth in the absence of
IPTG induction [39–41]. It has been proposed that leaky protein
expression occurs for lac-controlled systems when cells approach
stationary phase in complex medium and that cyclic AMP, acetate
and low pH are required to affect expression in the absence of IPTG
induction [42]. However, it has later been shown that unintended
induction in the pET system is likely due to the presence of as little
as 0.0001% of lactose in the medium [43].
Puriﬁcation of recombinantMtHisD has proved to be, at least in
our hands, not a trivial task. A number of protocols were attempted
to purify MtHisD enzyme to homogeneity with no success, even
using a His-tagged construction (data not shown). Incidentally,
His-tag puriﬁcation is not suitable in this case because imidazole,
used to elute proteins from afﬁnity columns seems, not surpris-
ingly, to inhibit the enzyme activity. In addition, MtHisD is a
metal-dependent enzyme (as will be described in the next section)
and the fusion of a His-tag to the recombinant protein could con-
found interpretation of results. Accordingly, we have opted to
use a construction without any fused partner. As MtHisD has a
low theoretical isoelectric point (pI = 4.85), it was deemed advan-
tageous to use a pH value as low as possible to reduce the likeli-
hood of E. coli proteins being adsorbed to the anion exchange
columns (Q Sepharose Fast Flow and Mono Q). Moreover, different
substances have different degrees of interaction with the ion
exchanger due to differences in their charges, charge densities
and distribution of charge on their surfaces, and these interactions
can be controlled by varying conditions such as pH. Hence,MtHisD
puriﬁcation protocol employed 100 mM Pipes pH 6.0 buffer for the
ﬁrst Q Sepharose Fast Flow anion exchange column, which resulted
in improved recombinant protein yield. Buffer exchange (from
buffer A to B) and salt removal were achieved in HiLoad Superdex
Table 1
Typical puriﬁcation protocol starting from 9 g of cells.
Sample Total
protein
(mg)
Total enzyme
activity (U)
Speciﬁc
activity
(U mg1)
Puriﬁcation
fold
Yield
(%)
Crude extract 693 24 0.03 1.0 100
Q Sepharose 60 28 0.5 17 117
Superdex 200 24 22 0.9 30 92
Mono Q 7.6 10 1.2 40 42
Fig. 2. SDS–PAGE analysis of pooled fractions of desorbed proteins for each
puriﬁcation step. (Lane 1) MW markers (Protein Marker – Fermentas); (Lane 2)
crude extract; (Lane 3) Q Sepharose Fast Flow ion exchange; (Lane 4) Superdex 200
gel ﬁltration and (Lane 5) Mono Q ion exchange.
Table 2
Effect of chelating agents and divalent metal ions on MtHisD enzyme activity.
Chelating agent/metal (mM) Speciﬁc activity (U mg1) Percentage (%)
Control 1.47 100
EDTA 0.1 1.74 118
1 1.98 135
10 1.41 96
1,10-Phenantroline
1 0.68 46
2 0.38 26
5 0.05 4
Zn2+ 40a 0.74 50
Mn2+ 40a 1.90 129
Mg2+ 40a 1.07 73
Ca2+ 40a 0.97 66
a Enzyme treated with 5 mM 1,10-phenantroline and diluted 10-fold prior to
assay.
J.E.S. Nunes et al. / Archives of Biochemistry and Biophysics 512 (2011) 143–153 147gel ﬁltration column. The third step of the puriﬁcation protocol
employed Mono Q anion exchange column that yielded MtHisD
in homogeneous form. This MtHisD puriﬁcation protocol yielded
approximately 7.6 mg of homogeneous enzyme having a speciﬁc
activity value of 1.2 U mg1 with approximately 40-fold puriﬁca-
tion using three chromatographic steps (Table 1). SDS–PAGE
analysis of total protein content for each chromatographic step is
shown in Fig. 2.N-terminal amino acid sequencing, electrospray ionization mass
spectrometry (ESI-MS) analysis, and oligomeric state determination
The ﬁrst 22 N-terminal amino acid residues were identiﬁed as
MLTRIDLRGAELTAAELRAALP by Edman degradation sequencing
method, in agreement to the Rv1599 protein-encoded sequence
available in the TubercuList database (http://www.genolist.
pasteur.fr/TubercuList/). This result unambiguously identiﬁes the
puriﬁed protein as MtHisD, since the ﬁrst 22 N-terminal amino
acids of HisD from E. coli are MSFNTIIDWNSCTAEQQRQLLM.
A value of 45,348.17 Da for the subunit molecular mass of
recombinant MtHisD was determined by ESI-MS, which is in
reasonably good agreement with the theoretical mass value of
45,378.2 Da. The ESI-MS result also revealed no peak at the
expected mass of E. coli HisD (46,110.3 Da), thus providing support
for the identity of puriﬁed recombinant protein. The Edman
degradation and ESI-MS results are also consistent with no
post-translational removal of N-terminal methionine residue
(131.2 Da).
A value of 101.8 kDa for the molecular mass of homogeneous
recombinant MtHisD was estimated by gel ﬁltration chromatogra-
phy (data not shown). This result demonstrates thatMtHisD is a di-
mer in solution, in agreement with HisD enzymes from other
organisms [22,23,44].Histidinol dehydrogenase as a metalloenzyme
As an attempt to ascertain whether or not MtHisD is a metal-
loenzyme, EDTA was added to the reaction mixture to observe
whether or not there would be a reduction in enzyme activity
due to divalent metal capture by the chelating agent. We have
previously observed that addition of 0.1 mM of EDTA to M. tuber-
culosis dehydroquinate synthase in the absence of substrates was
capable of abolishing enzyme activity after 10 min of incubation
[45]. However, direct addition of up to 1 mM EDTA showed no de-
crease in MtHisD enzyme activity and, even after incubating the
enzyme with 10 mM EDTA for 40 min, no loss of enzyme activity
could be observed (Table 2). Similar results have been observed
for HisD from S. typhimurium [13], from which metal content re-
moval was achieved using 1,10-phenantroline. Accordingly,
1 mM 1,10-phenantroline was added to the reaction mixture
resulting in a reduction of 46% in MtHisD enzyme activity in com-
parison to control (Table 2). However, measurements of time-
dependent inactivation of enzyme activity demonstrated that
there is a need to pre-incubate MtHisD in the presence of 1 mM
1,10-phenantroline for approximately 30 min to completely inac-
tivate the enzyme. Pre-incubation of MtHisD with 5 mM 1,10-phe-
nantroline for 3 min resulted in complete loss of enzyme activity.
These results suggest that MtHisD may contain a tightly bound
metal that plays an important role in the catalytic activity, which
could not be sequestered by EDTA but could be removed by 1,10-
phenantroline.
To evaluate divalent metal ions that could possibly rescue
MtHisD activity, recombinant enzyme was pre-incubated with
5 mM 1,10-phenantroline for 5 min and diluted 10-fold before
measuring enzyme activity. Interestingly, even upon dilution and
in the absence of any metal, very low enzyme activity was ob-
served for MtHisD treated with 1,10-phenantroline (data not
shown). Addition of Ca2+, Mg2+, Mn2+ and Zn2+ (40 mM) resulted
in regain of MtHisD activity (Table 2), whereas no enzyme activity
could be rescued upon addition of Cd2+, Co2+ and Ni2+ (40 mM)
(data not shown), as has been reported for S. thyphimurium [13]
and cabbage [46] enzymes.
Preliminary analysis to assess metal ion content indicated only
the presence of Zn2+, in concentrations above 500 ppm. Metal con-
centration analysis by ICP-AES yielded the following results: Zn2+,
6.52 mg L1 (99.6 lM) and Mn2+, <0.001 mg L1. These results
suggest a 0.56 ratio (99.6 lM/176.3 lM) of zinc per subunit. These
results are in agreement with previously reported data for S.
typhimurium [13] and B. oleracea [47] enzymes. However, the
ICP-AES data are somewhat puzzling as 40 mM Mn2+ could rescue
MtHisD enzyme activity more efﬁciently than 40 mM Zn2+
Fig. 3. Double-reciprocal plots of initial velocity experiments. (A) Varying L-Hol concentration a ﬁxed-varied concentrations of NAD+. (B) Varying and NAD+, concentration at
ﬁxed-varied concentrations of L-Hol. Fixed-varied concentrations of substrates are shown in each graph.
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is a Zn2+-dependent enzyme. HisD isolated from spring cabbage
heads was shown to be Mn2+-dependent [46]. How to reconcile
these apparently contradictory results? A possible explanation is
that MtHisD (here reported) was produced as a recombinant pro-
tein in E. coli, and hence being restricted to the metal content of
the host or growth media. The E. coli system to import manganese
is weakly expressed [48], thereby keeping low intracellular levels
of this metal, which could explain why we were unable to demon-
strate the presence of Mn2+ associated to MtHisD enzyme. It has
been demonstrated that Mn2+ can promptly replace Zn2+ in S. thy-
phimurium HisD enzyme [13]. However, it has been pointed out
that the physiological functions of Mn2+ in M. tuberculosis are still
poorly understood, and that several enzyme systems may prove
to be Mn2+-dependent however [49].
Steady state kinetics, ITC and enzyme mechanism
The overall reaction catalyzed by HisD can be analyzed as a ter-
reactant system in which NAD+ binds twice to the enzyme during
the course of the reaction, and participation of water is ignored as
its concentration remains constant. Lineweaver–Burk plots showed
a parabolic family of lines for varying L-Hol concentrations and
ﬁxed-varied NAD+ concentrations (Fig. 3A), and a linear pattern
of lines was observed for varying NAD+ concentrations at ﬁxed-
varied L-Hol concentrations (Fig. 3B). The double-reciprocal plots
for sequential mechanisms that involve MtHisD:L-Hol:2NAD+
quaternary complex formation would display a non-linear depen-
dence on NAD+ concentration, including Ordered Ter Ter, partially
Random Ter Ter and the completely Random Ter Ter mechanisms
[50]. On the other hand, for random mechanisms under steady-
state conditions the double-reciprocal plot would show a non-
linear dependence on the concentration of L-Hol, even though it
binds only once during the reaction sequence [50]. The linear inter-
secting lines observed for 1/[NAD+] and the parabolic family of
lines for 1/[LHol] may also suggest thatMtHisD follows a Ping-Pong
mechanism [24]. There are three possible Ping-Pong mechanisms:
Bi Uni Uni Bi, Bi Bi Uni Uni, and Hexa Uni [50]. The latter may be
discarded as it would give a pattern of parallel lines in double-re-
ciprocal plots for both substrates. A Bi Bi Uni Uni Ping-Pong mech-
anism would imply that the enzyme would have to exist as a
complex with NADH [50]. The value of 45,348.17 Da for the
subunit molecular mass of recombinant MtHisD determined byESI-MS is consistent with the absence of NADH tightly bound to
the enzyme as this value should be approximately 46,043.6 Da
(45378.2 + 665.4). Accordingly, the initial velocity data were best
ﬁtted to Eq. (2) for a Bi Uni Uni Bi Ping-Pong mechanism, yielding
values of 1.45 (±0.04)L s–1 for kcat, 4.9 (±0.6)  106 M for KM of
L-Hol, and 1.4 (±0.1)  103 M for KM of NAD+.
However, steady-state kinetic data alone could not rule out the
randommechanism. Of course, no mechanism is ever proved solely
by steady-state kinetic data; at best one can say that given the cur-
rent data the likely mechanism for MtHisD may be either random
or double displacement (Bi Uni Uni Bi Ping-Pong). Equilibrium bin-
ary complex formation studies were thus assessed by ITC measure-
ments to both provide thermodynamic signatures of non-covalent
interactions to each substrate(s)/product(s) binding processes and
distinguish between the possible enzyme mechanisms. No binding
of NAD+ or NADH to free MtHisD enzyme could be detected by ITC
measurements (Fig. 4). On the other hand, ITC measurements
showed binding of L-Hol and L-His to free MtHisD enzyme
(Fig. 4). These results support a Bi Uni Uni Bi Ping-Pong mechanism
in which L-Hol substrate binds to free enzyme followed by NAD+ to
form a MtHisD:L-Hol:NAD+ ternary complex that converts L-Hol
into L-Hal and release of NADH from the MtHisD:L-Hal:NADH
ternary complex (Fig. 1B). A second NAD+ molecule binds to
MtHisD:L-Hal binary complex to form MtHisD:L-Hal:NAD+ that
converts L-Hal into L-His in the presence of a water molecule
followed by release of NADH from MtHisD:L-His:NADH ternary
complex yielding the MtHisD:L-His binary complex, from which
L-His dissociates to give free MtHisD enzyme for the next round
of catalysis (Fig. 1B). It should be pointed out that although the
heat ﬂux did not allow reliable estimates for the thermodynamic
constants of MtHisD:L-His binary complex formation, it was possi-
ble to observe small heat changes between the binding reaction
and the control measurement. These data may indicate a large va-
lue for the overall dissociation constant for MtHisD:L-His binary
complex formation. In any case, the formation of the MtHisD:L-
Hol binary complex showed heat changes upon ligand titration
(Fig. 4). Fitting the data to one set of sites model yielded the follow-
ing values for thermodynamic signature of non-covalent interac-
tions upon binary complex formation: net unfavorable enthalpy
(DH = 3.6 ± 0.5 kcal/mol), favorable entropy (DS = 35 ± 13 cal/
mol K), and favorable Gibbs energy (DG = 7 ± 3 kcal/mol). In
addition, the value of 9 (±3) lM for the overall dissociation
constant at equilibrium of L-Hol binding to MtHisD is in good
Fig. 4. Isothermal titration calorimetry (ITC) curves for binding of (A) L-Hol (400 lM), (B) NAD+ (50 mM), (C) L-His (800 lM), and (D) NADH (50 mM) to recombinant MtHisD
(69 lM). Control experiments are show as empty circles and titration in the presence of enzyme as ﬁlled circles.
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unfavorable enthalpy was off-set by the large favorable entropy,
resulting in low equilibrium dissociation constant and a spontane-
ous reaction (DG favorable). The observed positive (unfavorable)
enthalpy value for MtHisD:L-Hol formation may be due to an unfa-
vorable redistribution of the network of interatomic interactions
(e.g., hydrogen bonds and van der Walls) between the reacting spe-
cies (including solvent) [51]. The observed positive (favorable) en-
tropy value for L-Hol binding to free MtHisD may be associated
with release of ‘‘bound’’ water molecules from the surface to the
bulk solvent [51].pH-rate proﬁles
To probe for acid–base catalysis, pH dependence studies of kcat,
and kcat/KM for L-Hol and NAD+ were performed. The pH-rate data
for kcat were ﬁtted to Eq. (4), indicating that protonation of a group
(slope of +1) with an apparent pK value of approximately 8 (±1)
(Fig. 5) abolishes catalysis. The pH-rate data for kcat/KM for L-Hol
were ﬁtted to Eq. (4), suggesting that protonation of a group (slope
of + 1) with an apparent pK value of approximately 8 (± 3) is
required for binding of L-Hol to free MtHisD (Fig. 5). These pKa’s
values may be attributed to conserved histidine residues present
Fig. 5. pH-rate proﬁles for the reaction catalyzed by MtHisD. Steady-state kinetic
constants were plotted in the logarithmic form against the pH value of the assay
mixture. (A) pH dependence of log kcat data were ﬁtted to Eq. (4); (B) pH
dependence data of kcat/KM for L-Hol were ﬁtted to Eq. (4); (C) pH dependence
data of kcat/KM for NAD+ were best ﬁtted to Eq. (5).
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azole side chain of L-His range from 6.0 to 7.0, amino acid residues
in biologically active proteins may have very different chemical
properties. A number of reports have shown similar pH proﬁles
suggesting that the side chain of histidine residue acts as a base
assisting the proton transfers during the overall catalysis
[47,52,53]. For instance, a value of log(kcat) and log(kcat/KM) titra-
tion proﬁles for the overall reaction with L-Hol as the variable sub-
strate indicated that the deprotonated form of a single ionizable
group with pK of 8.17 and 8.35 was essential for, respectively,
catalysis and substrate binding to S. typhimurium HisD [52]. Essen-
tial roles for histidines in HisD mode of action have also been
shown by site-directed mutagenesis [47,53] and structural studies
[23]. The crystal structure of E. coli HisD [23] showed that the hy-
droxyl group of L-Hol forms H-bonds to the backbone carbonyl ofHis367 (corresponding to His376 in MtHisD) and to the His327Ne2
atom (corresponding to His336 in MtHisD). It is thus tempting to
suggest that the conserved imidazole group of His336 plays a crit-
ical role in both catalysis and L-Hol binding toMtHisD. The data for
kcat/KM for NAD+ were best ﬁtted to Eq. (5), which describes a bell-
shaped pH-rate proﬁle for a single ionizing group in the acidic limb
that must be unprotonated for NAD+ binding and participation of a
single ionizing group in the basic limb that must be protonated for
substrate binding. These pK values differ by less than a pH unit
however. Data ﬁtting yielded an apparent pK value of 9.2, which
is a mean of the two residues. The E. coli HisD structure showed
the phosphate groups of NAD+ make H-bonds to Asn211, Tyr130,
and Gly133 via a bridging water molecule [23]. The adenosine su-
gar O20 is H-bonded to Gln188 side chain, whereas O40 interacts
with Asn211, and the adenine N3 atom makes an H-bond to
Gln188 via a water molecule [23]. The two likely candidates that
play a role in NAD+ binding to MtHisD are the conserved Tyr129
and Tyr223 (Fig. 6). Although the sequence alignment helps infer
amino acids involved in catalysis and/or binding, the molecular
model (presented in more detail in the next section) suggests that
the Tyr129, Tyr223 and His335 residues make contacts with the
substrates in theMtHisD enzyme active site (Fig. 7). Notwithstand-
ing, the rate expression for kcat/KM starts with the combination of
substrate and enzyme and includes all steps through the ﬁrst irre-
versible one, which is usually either release of the ﬁrst product or
an irreversible chemical step prior to this. In addition, the pH-
dependent proﬁle for kcat reports on events following the
enzyme-substrate complex formation capable of undergoing catal-
ysis, which include the chemical steps, possible enzyme conforma-
tional changes, and product release (leading to regeneration of free
enzyme). Hence, the ionization of a group observed in the pH pro-
ﬁle for kcat/KM includes both binding and catalytic steps. Accord-
ingly, participation of ionizing groups solely in catalysis cannot
be ruled out for the pKs derived from the acidic limbs of the pH
proﬁles for kcat/KM (Fig. 5B and C). On the other hand, participation
of a single ionizing group in the basic limb with apparent pK value
of 9.2 derived from the pH proﬁle of kcat/KM for NAD+ can be attrib-
uted to substrate binding, as the pH proﬁle for kcat shows no ioniz-
ing group involved in catalysis in the basic limb (Fig. 5C). At any
rate, site directed mutagenesis efforts should be pursued to assign
a deﬁnite role in catalysis and/or binding to these amino acid side
residues.
Three-dimensional model analysis
The three-dimensional structure of E. coli HisD has been deter-
mined by X-ray diffraction in the apo state as well as in complex
with L-Hol, Zn+2 and NAD+ at 1.7 Å resolution [23], which was em-
ployed as template for molecular homology modeling of MtHisD
structure. E. coli HisD protein sequence is four amino acids shorter
than MtHisD (434 and 438 amino acids, respectively). Although
small gaps were included, there exists high sequence conservation
with 36% identity (Fig. 6), which satisﬁes homology modeling
premises [30] and lends support to using E. coli HisD as a suitable
template. There are no major structural rearrangements upon
NAD+, L-Hol, and Zn2+ binding as compared to the apo form of
E. coli HisD [23], with RMSD value of just 1 Å when all alpha carbon
coordinates are considered. Stereochemical analysis by PROCHECK
[33] showed that 91% of MtHisD amino acid residues are in the
most favored regions of the Ramachandran plot, validating our
model as suitable for structural inferences.
Most signiﬁcant structural variations are observed at the
C-termini of eachMtHisD subunit (RMSD value of 3.08 Å). The HisD
monomer consists of four domains; two larger globular domains
(domain 1, amino acid residues 25–103, 124–247 and domain 2,
amino acids 1–24, 237–381) with an a/b/a topology, in which
Fig. 6. Neighbor-joining multi sequence alignment of M. tuberculosis (TubercuList: Rv1599), E. coli (UniProt: P06988), S. thyphimurium (GenBank: NP_461017.1) and B.
oleracea (GenBank: AAA32991.1) HisD enzymes, performed with ClustalW (1). B. oleracea ﬁrst 23 amino acids were omitted from alignment. Amino acid conservation, strong
similarity, weak similarity and in/del are denoted as, respectively, ⁄, :, ., and –. Amino acids involved in substrates binding are shaded in gray.
Fig. 7. ProposedMtHisD residues involved in substrate binding and/or catalysis. All
residues are less than 4.0 Å from substrates.
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folds lacking one strand-helix hairpin. A third domain (domain 3,
amino acids 104–123 and 400–409) is composed by a three-
stranded antiparallel b-sheet that extends away from the two glob-
ular domains. The fourth domain (domain 4, residues 410–437)
folds into a small V-shaped two-helical hairpin that is perpendicu-
lar to the third domain antiparallel b-sheet (Fig. 8A). Structural
variation is observed at the C-termini, explicitly at domain 4,
where the second helix of the helical hairpin has moved away fromthe substrate and Zn+2 binding site (Fig. 8B). This displacement of
7 Å of the side chains of the amino acids involved in L-Hol and
Zn+2 binding may be a result of domain 4 ﬂexibility. The crystallo-
graphic structure of E. coli HisD showed no major structural rear-
rangement upon binding of substrates [23].
Substrate and Zn+2 binding sites are located on the homodimer
interface, NAD+ binding site is located at domain 1, at the incom-
plete Rossmann fold structural motif.MtHisD amino acids involved
in L-Hol binding are His336 and His376 from domain 2 and Glu423
of domain 4 (Fig. 6). The Zn+2 ion is octahedrally coordinated to
Gln267, His270, Asp369, His428, and two ligands from L-Hol.
Amino acid residues contributing to NAD+ binding include
Tyr129, Gly132, and Asn221 (phosphate binding); Gln193 and
Asn221 (adenosine sugar binding); and Phe58, Gln193, and
Tyr223 (adenine base binding). The conservation of these amino
acid residues is noticeable, being all but Tyr223 conserved among
MtHisD homologues (Fig. 6). Although not directly involved in HisD
catalysis, Zn+2 interacts with the amino group of histidinol that has
been suggested to play a role in the correct positioning of L-Hol in
the enzyme active site [23].
A proposal for the E. coli HisD reaction mechanism has been put
forward which involves abstraction of the hydroxyl group proton
of L-Hol by His327 (MtHisD His336) and concomitant hydride
transfer from the reactive carbon (carbon bound to the hydroxyl
group that upon hydride transfer adopts the sp2 conﬁguration)
to NAD+, forming L-Hal and transiently protonated His327 (MtHisD
His336) [23]. A neighboring water molecule is activated by Glu326
(MtHisD Glu335) to make a nucleophilic attack on the carbonyl
carbon with concomitant protonation of aldehyde oxygen by the
transiently protonated His327 (MtHisD His336), leading to the
formation of an L-histidindiol (gem-diol) intermediate. Hydride
transfer to NAD+ from now sp3-gem-diol carbon of -CH-(OH)2
intermediate with concomitant proton abstraction from a sub-
strate hydroxyl group by unprotonated His327 (MtHisD His336)
form the sp2-carbon of the carboxylate group of L-His. The proton-
ated His327 (MtHisD His336) is thought to donate a proton to a
water molecule. NMR studies indicated that the metal ion interacts
with the imidazole portion of the substrate and acts as a Lewis acid
Fig. 8. Molecular model of MtHisD. (A) Three-dimensional structure of the MtHisD monomer, indicating its globular domains (1 and 2), the helical-hairpin (domain 4), and
the connective three-stranded antiparallel b-sheet (domain 3). (B) MtHisD homodimeric three-dimensional structure, subunit A in light gray and subunit B in dark gray. The
L-shaped arm formed by domains 3 and 4 extends from each monomer and forms a latch-like structure that closes upon domains 1⁄ and 2⁄ of the other monomer (asterisks
are residues from the neighboring monomer). The two active sites of MtHisD protein are located at the boundaries of the homodimer interface (arrows). Amino acid residues
from both subunits make H- bonds to L-Hol and Zn2+ (domains 1, 2, and 4⁄); and NAD+ is H-bonded to amino acids from domain 1.
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tibility to nucleophilic attack for the aldehyde oxidation [54]. How-
ever, structural analysis of E. coli HisD prompted the authors to
suggest that Zn2+ plays a role in proper positioning of L-Hol [23].
As pointed out in the previous section, the conserved imidazole
group of His336 is likely the residue with pK value of approxi-
mately 8 that plays a critical role in catalysis and L-Hol binding
(Fig. 5A and B). A value ranging from 4.3 to 4.5 is usually observed
for pK of the c-carboxyl group of glutamate, although it depends on
the chemical context of an enzyme active site. The pH-rate data for
MtHisD have not provided a clear evidence for participation of, for
instance, Glu335 in either catalysis or substrate binding. Accord-
ingly, site-directed mutagenesis will have to be pursued to reveal
whether or not this amino acid side chain plays any role in the
mode of action of MtHisD enzyme.Conclusion
In the present work, PCR ampliﬁcation, cloning and sequencing
of hisD gene from M. tuberculosis H37Rv strain are described. Data
on recombinant MtHisD protein puriﬁcation, N-terminal amino
acid sequencing and electrospray ionization mass spectrometry
analyses were presented to conﬁrm the identity of the recombi-
nant protein. Analytical gel ﬁltration, inactivation by chelating
agents, activation by divalent metal ions, and inductively coupled
plasma atomic emission spectroscopy (ICP-AES) analysis of metal
content indicated that MtHisD is a homodimeric metalloprotein.
Steady-state kinetics and ITC studies suggested that MtHisD fol-
lows a Bi Uni Uni Bi Ping-Pong mechanism, in which L-Hol sub-
strate binds to free enzyme followed by NAD+ to form a
MtHisD:L-Hol:NAD+ ternary complex that converts L-Hol into L-
Hal and release of NADH from the MtHisD:L-Hal:NADH ternary
complex. A second NAD+ molecule binds to MtHisD:L-Hal binary
complex to form MtHisD:L-Hal:NAD+ that converts L-Hal into L-
His in the presence of a water molecule followed by release of
NADH from MtHisD:LHis:NADH ternary complex yielding the
MtHisD:L-His binary complex, from which L-His dissociates to give
free MtHisD enzyme for the next round of catalysis. Based on
pH-rate proﬁles, primary sequence comparisons, and molecular
homology modeling of MtHisD, the likely amino acid residues
involved in acid–base catalysis and/or substrate binding are pro-
posed. Further efforts to provide a more detailed picture ofMtHisD
mode of action will include, but not be limited to, site-directedmutagenesis, chemical rescue, isotope effects, pre-steady state
kinetics, and crystal structure determination.
Acknowledgments
This work was supported by funds of Decit/SCTIE/MS-MCT-
CNPq-FNDCT-CAPES to National Institute of Science and Technol-
ogy on Tuberculosis (INCT-TB) to D.S.S. and L.A.B. L.A.B. and D.S.S.
also acknowledge ﬁnancial support awarded by FAPERGS-CNPq-
PRONEX-2009. D.S.S. (CNPq, 304051/1975-06) and L.A.B. (CNPq,
520182/99-5) and are Research Career Awardees of the National
Research Council of Brazil (CNPq). J.E.S.N. and L.A.R. acknowledge
scholarships awarded by CNPq. A.B. acknowledges a scholarship
awarded by BNDES.
References
[1] World Health Organization, Global tuberculosis control: WHO report 2010,
Geneva, Switzerland, WHO/HTM/TB/2010.7.
[2] World Health Organization, Global tuberculosis control: epidemiology,
strategy, ﬁnancing, WHO report 2009, Geneva, Switzerland, WHO/HTM/TB/
2009.411.
[3] D. Kumar, K.V.S. Rao, Regulation between survival persistence, Microbes Infect.
13 (2011) 121–133.
[4] A.A. Velayati, P. Farnia, M.R. Masjedi, T.A. Ibrahim, P. Tabarsi, R.Z. Haroun, H.O.
Kuan, J. Ghanavi, P. Farnia, M. Varahram, Totally drug-resistant tuberculosis
strains: evidence of adaptation at the cellular level., Eur. Resp. J. 34 (2009)
1202–1203.
[5] A.A. Velayati, Chest 136 (2009) 420–425.
[6] A. Koul, E. Arnoult, N. Lounis, J. Guillemont, K. Andries, Nature 469 (2011) 483–
490.
[7] M.E. Winkler, Biosynthesis of Histidine, in: F.C. Neidhardt (Ed.), Escherichia coli
and Salmonella: Cellular and Molecular Biology, ASM Press, Washington, DC,
1996, pp. 485–505.
[8] E. Adams, J. Biol. Chem. 209 (1954) 829–846.
[9] E. Adams, J. Biol. Chem. 217 (1955) 325–344.
[10] J.C. Loper, E. Adams, J. Biol. Chem. 240 (1965) 788–795.
[11] S.Y. Lee, C.T. Grubmeyer, J. Bacteriol. 169 (1987) 3938–3944.
[12] A. Nagai, K. Suzuki, E. Ward, M. Moyer, M. Hashimoto, J. Mano, D. Ohta, A.
Scheidegger, Arch. Biochem. Biophys. 295 (1992) 235–239.
[13] C. Grubmeyer, M. Skiadopoulos, A.E. Senior, Arch. Biochem. Biophys. 272
(1989) 311–317.
[14] D. Voet, J.D. Voet, Amino acid metabolism, in: D. Voet, J.D. Voet (Eds.),
Biochemistry, John Wiley & Sons, Inc., USA, 1995, pp. 727–784.
[15] S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K.
Eiglmeier, S. Gas, C.E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T.
Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin,
S. Holroyd, T. Hornsby, K. Jagels, B.G. Barrel, Nature 393 (1998) 537–544.
[16] T. Parish, J. Bacteriol. 185 (2003) 6702–6706.
[17] C.M. Sassetti, D.H. Boyd, E.J. Rubin, Mol. Microbiol. 48 (2003) 77–84.
[18] T. Parish, B.G. Gordhan, R.A. McAdam, K. Duncan, V. Mizrahi, N.G. Stoker,
Microbiology 145 (1999) 3497–3503.
J.E.S. Nunes et al. / Archives of Biochemistry and Biophysics 512 (2011) 143–153 153[19] F. Agüero, B. Al-Lazikani, M. Aslett, M. Berriman, F.S. Buckner, R.K. Campbell, S.
Carmona, I.M. Carruthers, A.W.E. Chan, F. Chen, G.J. Crowther, M.A. Doyle, C.
Hertz-Fowler, A.L. Hopkins, G. McAllister, S. Nwaka, J.P. Overington, A. Pain,
G.V. Paolini, U. Pieper, S.A. Ralph, A. Riechers, D.S. Roos, A. Sali, D. Shanmugam,
T. Suzuki, W.C. Van Voorhis, C.L.M.J. Verlinde, Nat. Rev. Drug Discov. 7 (2008)
900–907.
[20] M.M. Bradford, Anal. Biochem. 72 (1976) 248–254.
[21] H. Chassaigne, R. Lobinski, Analyst 123 (1998) 2125–2130.
[22] A. Kheirolomoom, J. Mano, A. Nagai, A. Ogawa, G. Iwasaki, D. Ohta, Arch.
Biochem. Biophys. 312 (1994) 493–500.
[23] J.A.R.G. Barbosa, J. Sivaraman, Y. Li, R. Larocque, A. Matte, J.D. Schrag, M. Cygler,
Proc. Natl. Acad. Sci. USA 99 (2002) 1859–1864.
[24] I.H. Segel, Enzyme Kinetics – Behavior Analysis of Rapid Equilibrium and
Steady-state Enzyme Systems, Wiley, Classics Library Edition, Wyley-
Interscience Publication, John Wiley & Sons, Inc., New York, 1993.
[25] P.F. Cook, W.W. Cleland, Enzyme Kinetics and Mechanism, Garland Science,
New York, 2007.
[26] S.F. Altschul, T.L. Madden, A.A. Schäffer, J. Zhang, Z. Zhang, W. Miller, D.J.
Lipman, Nucleic Acids Res. 25 (1997) 3389–3402.
[27] H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat,
H. Weissig, I.N. Shindyalov, P.E. Bourne, Nucleic Acids Res. 28 (2000)
235–242.
[28] J.D. Thompson, D.G. Higgins, T.J. Gibson, Nucleic Acids Res. 22 (1994) 4673–
4680.
[29] A. Šali, T.L. Blundell, J. Mol. Biol. 234 (1993) 779–815.
[30] M.A. Martí-Renom, A.C. Stuart, A. Fiser, R. Sánchez, F. Melo, A. Šali, Annu. Rev.
Biophys. Biomol. Struct. 29 (2000) 291–325.
[31] A. Šali, J.P. Overington, Protein Sci. 3 (1994) 1582–1596.
[32] M.Y. Shen, A. Šali, Protein Sci. 15 (2006) 2507–2524.
[33] R.A. Laskowski, M.W. MacArthur, D.S. Moss, J.M. Thornton, J. Appl. Cryst. 26
(1993) 283–291.
[34] D.A. Case, D.A. Pearlman, J.W. Caldwell, T.E. Cheatham III, J. Wang, W.S. Ross,
C.L. Simmerling, T.A. Darden, K.M. Merz, R.V. Stanton, A.L. Cheng, J.J. Vincent,
M. Crowley, V. Tsui, H. Gohlke, R.J. Radmer, Y. Duan, J. Pitera, I. Massova, G.L.Seibel, U.C. Singh, P.K. Weiner, P.A. Kollman, AMBER 7. University of California,
San Francisco, 2002.
[35] D. van der Spoel, E. Lindahl, B. Hess, G. Groenhof, A.E. Mark, H.J.C. Berendsen, J.
Comp. Chem. 26 (2005) 1701–1718.
[36] W.L. DeLano, The PyMOL Molecular Graphics System. DeLano Scientiﬁc, San
Carlos, CA, USA, 2002, Available from: <http://www.pymol.org>.
[37] P.R. Winship, Nucleic Acids Res. 17 (1989) 1266.
[38] K.C. Kelley, K.J. Huestis, D.A. Austen, C.T. Sanderson, M.A. Donoghue, S.K.
Stickel, E.S. Kawasaki, M.S. Osburne, Gene 156 (1995) 33–36.
[39] J.S. Oliveira, C.A. Pinto, L.A. Basso, D.S. Santos, Protein Expr. Purif. 22 (2001)
430–435.
[40] M.L. Magalhaes, C.P. Pereira, L.A. Basso, D.S. Santos, Protein Expr. Purif. 26
(2002) 59–64.
[41] R.G. Silva, L.P. Carvalho, J.S. Oliveira, C.A. Pinto, M.A. Mendes, M.S. Palma, L.A.
Basso, D.S. Santos, Protein Expr. Purif. 27 (2003) 158–164.
[42] T.H. Grossman, E.S. Kawasaki, S.R. Punreddy, M.S. Osburne, Gene 209 (1998)
95–103.
[43] F.W. Studier, Protein Expr. Purif. 41 (2005) 207–234.
[44] E. Burger, H. Gorisch, F. Lingens, Biochem. J. 181 (1979) 771–774.
[45] J.D. de Mendonça, O. Adachi, L.A. Rosado, R.G. Ducati, D.S. Santos, L.A. Basso,
Mol. BioSyst. 7 (2011) 119–128.
[46] A. Nagai, A. Scheidegger, Arch. Biochem. Biophys. 284 (1991) 127–132.
[47] A. Nagai, D. Ohta, J. Biochem 115 (1994) 22–25.
[48] A. Anjem, S. Varghese, J.A. Imlay, Mol. Microbiol. 72 (2009) 844–858.
[49] D. Agranoff, S. Krishna, Front. Biosci. 9 (2004) 2996–3006.
[50] H. Görisch, Biochem. J. 181 (1979) 153–157.
[51] R. O’Brien, I. Haq, Applications of Biocalorimetry: Binding, Stability and
Enzyme Kinetics, in: J.E. Ladbury, M.L. Doyle (Eds.), Biocalorimetry 2:
Applications of Calorimetry in the Biological Sciences, John Wiley & Sons,
Ltd., West Sussex, 2004, pp.3–34.
[52] C. Grubmeyer, H. Teng, Biochemistry 38 (1999) 7355–7362.
[53] H. Teng, C. Grubmeyer, Biochemistry 38 (1999) 7363–7371.
[54] K. Kanaori, N. Uodome, A. Nagai, D. Ohta, A. Ogawa, G. Iwasaki, A.Y. Nosaka,
Biochemistry 35 (1996) 5949–5954.
